Restless Legs Syndrome in Women: Iron, Pregnancy & Treatment

• RLS is a genuine neurological disorder, not anxiety. It causes an irresistible urge to move the legs that worsens at rest and in the evening, and eases with movement.
• Iron deficiency is the leading reversible cause. In RLS, doctors aim for a ferritin above 75 ng/mL, higher than the usual anaemia target, and many Indian women fall below this.
• Pregnancy roughly triples the risk; 20-25% of pregnant women get RLS, usually in the third trimester. An iron-first approach is preferred.
• Under 2024 American Academy of Sleep Medicine guidance, gabapentinoids (gabapentin, pregabalin) are now first-line drugs for moderate-to-severe RLS, ahead of dopamine agonists.
• Many everyday medicines, some antidepressants, sedating antihistamines and anti-nausea pills like metoclopramide, make RLS worse and can be swapped.
• Effective treatment exists. Untreated RLS damages sleep, mood and quality of life, so it is worth taking seriously and treating properly.

Restless legs syndrome is a sensorimotor disorder: an uncomfortable sensation deep in the legs (occasionally the arms) paired with an overwhelming urge to move. Women describe it as creeping, crawling, tingling, pulling, itching, electric, or simply a need to keep moving that they cannot ignore.

Four features set it apart from ordinary leg discomfort. The urge to move comes on or worsens at rest, while sitting or lying down. It eases, at least partly, when you walk, stretch or massage the legs. And it follows a clock, building in the evening and peaking around bedtime. This nightly timing is why RLS so often wrecks sleep before it is ever named.

Doctors use the International Restless Legs Syndrome Study Group (IRLSSG) criteria, all four of which must be present: an urge to move the legs, usually with uncomfortable sensations; symptoms that begin or worsen during rest; relief with movement; and symptoms that are worse in the evening or at night. The symptoms must not be fully explained by something else, such as leg cramps, positional discomfort, neuropathy or anxiety.

RLS is roughly twice as common in women as in men. Several factors stack the odds for Indian women in particular: widespread iron deficiency, monthly menstrual blood loss, the lower iron absorption of largely vegetarian diets, the heavy iron demands of pregnancy, and conditions such as chronic kidney disease and thyroid disorders. On top of biology sits a cultural problem, women's fatigue and restlessness are often brushed aside as stress or "weakness," so the condition goes unnamed for years.

There is no single test for RLS. The diagnosis is clinical, based on the four IRLSSG criteria and a careful history: the nature and timing of the sensations, whether movement relieves them, how badly they affect sleep and daytime function, family history (a first-degree relative raises your risk several-fold), pregnancy status, and a full list of current medicines.

To grade severity, clinicians often use the IRLS rating scale (10 questions, scored 0-40): mild 1-10, moderate 11-20, severe 21-30, very severe 31-40. This guides treatment and tracks whether it is working.

Where blood tests matter is in hunting for reversible causes. Expect serum ferritin and iron studies (a ferritin below 75 ng/mL is treated even without anaemia), a complete blood count, kidney and thyroid function, vitamin B12, folate and vitamin D, and a blood sugar check. Several of these overlap with conditions women are often already low in, so it is worth reading our deep dives on iron deficiency in non-pregnant women, vitamin B12 deficiency and vitamin D deficiency.

RLS is also frequently confused with other conditions. Peripheral neuropathy (from diabetes, B12 deficiency or alcohol) usually causes steady numbness or burning rather than an urge to move. Leg cramps are sudden, painful contractions. Akathisia is a drug-induced, whole-body restlessness, often from antipsychotics or anti-nausea medicines, rather than a leg-specific sensation. Vascular claudication hurts with exertion, not rest. Periodic limb movement disorder, involuntary leg jerks during sleep, is a close relative that often coexists with RLS and shows up on a sleep study.

Iron is the most important reversible cause of RLS, and it is where treatment should usually begin. Crucially, you do not need to be anaemic for iron to matter: even mild iron deficiency, with ferritin in the 30-75 ng/mL range, can trigger or worsen symptoms. This is because RLS is driven partly by low iron in the brain, which blood haemoglobin does not reliably reflect.

That is why RLS uses a higher iron target than general anaemia care. The aim is a ferritin above 75-100 ng/mL, and some women need it pushed towards 100-200 ng/mL before symptoms settle. When iron correction works, it improves RLS in roughly 50-70% of iron-deficient patients over 3-6 months, and can reduce or remove the need for any other medication. Given how common low iron is in Indian women, this step is too often skipped. Our deep dive on anaemia causes in Indian women and guide to iron-deficiency symptoms explain who is most at risk.

Oral iron is the usual starting point: ferrous sulfate (cheapest, sometimes harder on the stomach), ferrous ascorbate, ferrous fumarate, iron polymaltose or iron amino-acid chelate (gentler, better absorbed, dearer). A common dose is 65-200 mg of elemental iron daily, titrated against repeat ferritin. Take it with vitamin C to boost absorption, and away from tea, coffee, milk, calcium or high-fibre meals, which block it. Iron tablets are free at primary and community health centres under Anemia Mukt Bharat, and Jan Aushadhi pharmacies stock them at a steep discount.

When oral iron is not tolerated or simply does not raise ferritin, intravenous iron is an option: iron sucrose (given over several sessions) or single high-dose infusions of ferric carboxymaltose or iron isomaltoside. It is used for severe RLS, poor oral response, or conditions that impair absorption such as kidney or bowel disease. Each infusion takes 30-60 minutes at a clinic, is generally well tolerated, and ferritin is rechecked 3-6 months later. Serious reactions are rare.

RLS drug treatment changed direction in 2024. The American Academy of Sleep Medicine (AASM) now recommends gabapentinoids, gabapentin, gabapentin enacarbil and pregabalin, as first-line drugs for moderate-to-severe RLS, ahead of the dopamine agonists that were standard for decades. The reason is augmentation: a paradoxical worsening in which symptoms start earlier in the day, spread to the arms, or intensify the longer a dopamine agonist is taken. In settings where a prescription may run for years without specialist review, this matters a great deal.

In India, gabapentin is the most accessible option (generic brands such as Gabapin and Gabantin, roughly Rs 200-500 a month). Treatment usually starts at a low test dose of 100-300 mg about two hours before bed, then titrates up to an effective 600-1,200 mg; many women settle at the lower end, which limits daytime grogginess. Pregabalin (Rs 600-2,000 a month) is an alternative, already familiar in India for diabetic neuropathy and fibromyalgia. Both calm the over-active nerve signalling behind the "creepy-crawly" sensations and are taken once at night, which also helps sleep.

The rule is "start low, go slow." Side effects include dizziness, morning drowsiness, weight gain and ankle swelling (pedal oedema), the last of which women sometimes mistake for a heart or kidney problem. Because these drugs are cleared by the kidneys, get a serum creatinine checked first; the dose must be reduced if kidney function is impaired, so this links closely to RLS in chronic kidney disease. A practical tip: if symptoms reliably start during evening cooking or TV time, taking the dose at 5-6 pm lets the peak effect land in the hardest hours while easing early-morning brain fog.

Gabapentin enacarbil (a longer-acting prodrug) is specifically recommended by the AASM but is costlier (around Rs 2,000-5,000 a month) and harder to find outside larger cities, so most Indian neurologists rely on generic gabapentin or pregabalin. These are prescription (Schedule H) medicines and should not be stopped abruptly, which can cause rebound insomnia or anxiety. Where families view nerve or sleep medication with suspicion, it can help to frame these as "calming agents for over-active nerves" rather than sleeping pills, and to keep checking iron alongside: if ferritin is below 75-100 ng/mL, iron is corrected first or in parallel.

Dopamine agonists were first-line for RLS for years and were demoted in the 2024 AASM guidance because of augmentation, the gradual, paradoxical worsening of RLS on the very drug meant to treat it. It affects an estimated 30-50% of patients on these drugs at five years or more, and reversing it can mean switching drug classes entirely.

Ropinirole (roughly Rs 200-800 a month) is started at 0.25 mg one to two hours before bed and titrated up to 0.5-4 mg. Pramipexole (about Rs 300-1,000 a month) starts at 0.125 mg two to three hours before bed, up to 0.25-0.75 mg, with long-acting versions available. Both can cause nausea, daytime sleepiness, low blood pressure and, importantly, impulse-control disorders, compulsive gambling, shopping or hypersexuality, which must be discussed openly and reviewed at every visit.

A rotigotine transdermal patch gives steadier drug levels and sometimes less augmentation, but it is expensive and not widely available in India. Levodopa is generally avoided for RLS because its augmentation risk is high.

If a dopamine agonist is used, the approach is: lowest effective dose; check at every visit for augmentation (earlier onset, greater intensity, spread to other body parts) and for impulse-control symptoms; and, if augmentation appears, taper off while transitioning to a gabapentinoid or, rarely, a low-dose opioid.

When iron and gabapentinoids both fail, this is called refractory RLS, specialist neurologists at centres such as AIIMS Delhi or PGIMER may consider low-dose opioids. These are never first-line and are reserved for severe cases where sleep is destroyed. Tramadol is sometimes used; for treatment-resistant cases, methadone is notable for a lower augmentation risk, but all opioids carry risks of constipation, dependency and, at higher doses, breathing suppression, and stronger agents fall under NDPS regulations.

Benzodiazepines such as clonazepam are sometimes added to help maintain sleep. They do not touch the underlying urge to move, and tolerance plus morning grogginess limit their long-term use, so they are best treated as occasional adjuncts rather than core therapy.

Lifestyle measures are the backbone of long-term control. Moderate exercise, a brisk evening walk or gentle calf stretches, helps, though very vigorous late-night activity can backfire. Familiar home comforts genuinely work: a warm mustard-oil leg massage (malish), or alternating warm and cool compresses on the calves before bed. Cutting evening caffeine, the multiple cups of strong masala chai in particular, and avoiding alcohol and tobacco lowers the frequency of flares. Fifteen to twenty minutes of yoga or pranayama can settle the nervous system before sleep, and these non-drug measures are especially valuable in the third trimester of pregnancy when medication choices are limited.

Travel deserves planning. Long bus, train or car journeys for weddings and festivals can be miserable, so build in hourly movement breaks to stretch your legs. And whatever else is being used, iron status remains the foundation: even on other treatments, ferritin should be rechecked, and free iron-folic acid is distributed through government maternal-health programmes.

Finally, advocate for yourself. RLS is a real neurological condition, not laziness or "acting out," and explaining to your family that the need to move is a physiological requirement helps secure support for treatment. The Indian Academy of Neurology and patient-education resources can help demystify it for caregivers.

Before adding any new RLS drug, audit the medicine cabinet, because the trigger is often something already being taken. Several antidepressants are common culprits: SSRIs such as escitalopram and fluoxetine, SNRIs such as venlafaxine and duloxetine, tricyclics such as amitriptyline, and mirtazapine (a particularly strong trigger). If RLS flares on an antidepressant, ask your doctor about bupropion, which generally does not worsen RLS, or trazodone. Never stop a psychiatric medicine on your own; these conversations belong with the prescriber, and our guide to accessing mental-health treatment for women may help.

The most avoidable triggers in India are dopamine-blocking anti-nausea and "gastric" medicines. Metoclopramide (sold as Perinorm) and prochlorperazine (Stemetil), routinely prescribed for morning sickness, migraine or indigestion, can set off a severe flare or akathisia. Ondansetron is usually a much safer anti-nausea alternative. The same dopamine-blocking effect applies to antipsychotics such as olanzapine, risperidone, quetiapine, aripiprazole and haloperidol.

Over-the-counter habits matter too. Sedating antihistamines, pheniramine (Avil) and diphenhydramine, worsen RLS, and even cetirizine triggers it in some women; these hide inside night-time cold-and-flu sachets used as makeshift sleep aids. Safer choices are non-sedating antihistamines like fexofenadine or loratadine. Always read the salt name on the strip.

Lifestyle triggers round out the list: caffeine (especially repeated cups of strong masala chai), alcohol, and nicotine in any form including gutka. Beta-blockers such as propranolol and the mood stabiliser lithium can also aggravate symptoms. A useful step is a one-week symptom diary noting every pill, including any Ayurvedic or AYUSH supplement, to bring to your doctor. Removing a single unnecessary trigger is often cheaper and more effective than starting a lifelong new medication.

Pregnancy is one of the strongest triggers for RLS: 20-25% of pregnant women experience it, usually in the third trimester, sometimes for the first time. The drivers are the rapid iron drain of pregnancy (the growing baby, placenta and expanded blood volume all demand iron), hormonal effects on the dopamine system, circulatory changes, and any underlying genetic tendency.

Diagnosis uses the same IRLSSG criteria, with careful attention to iron status (the RLS-relevant ferritin threshold of around 75 ng/mL still applies in pregnancy) and to ruling out look-alikes, especially pregnancy leg cramps, which are common but feel quite different.

Treatment leans firmly on iron and lifestyle. High-dose oral iron is used if ferritin is below 75 ng/mL, taken with vitamin C; intravenous iron is generally considered safe in the second and third trimesters for severe symptoms with a poor oral response. Non-drug measures, avoiding triggers (including metoclopramide, which is commonly given for pregnancy nausea), gentle exercise, leg massage, warm baths and a regular sleep schedule, do much of the work. For a focused walkthrough, see our dedicated guide to restless legs syndrome in pregnancy and to anaemia in pregnancy.

Most RLS drugs are either poorly studied or potentially risky in pregnancy, so dopamine agonists, gabapentinoids, benzodiazepines and opioids are generally avoided except in severe, refractory cases under specialist guidance. The reassuring news is that symptoms usually settle within days to weeks after delivery as iron and hormones recover, though RLS can persist while breastfeeding, where it is managed with iron and feeding-compatible options. Restoring iron stores postpartum matters here too, as covered in postpartum iron recovery.

RLS rarely travels alone. It commonly overlaps with insomnia, since it disrupts both falling and staying asleep; with periodic limb movement disorder (present in 80%+ of people with RLS); with obstructive sleep apnoea, worth treating in its own right, as in sleep apnoea in postmenopausal women; with chronic kidney disease (40-50% of dialysis patients have RLS); and with diabetes, thyroid disease and iron-deficiency anaemia. Where mood symptoms are prominent, our guide to thyroid symptoms in women and type 2 diabetes in women are useful cross-references.

There are good reasons not to let severe RLS run untreated. It is associated with higher blood pressure and increased cardiovascular risk, thought to be driven by the repeated night-time arousals, sympathetic activation and fragmented sleep that come with periodic limb movements. Adequate treatment may help reduce these risks.

The mental-health toll is real too. Severe RLS erodes mood, concentration and daytime productivity, and depression and anxiety are common companions. Treating the RLS often lifts mood; where low mood persists, it deserves its own treatment, ideally with CBT or an RLS-friendly antidepressant such as bupropion rather than the SSRIs and SNRIs that aggravate symptoms.

Long term, RLS is monitored at each review: symptom severity, sleep quality, daytime function, medication response and side effects, augmentation and impulse-control symptoms in anyone on a dopamine agonist, and periodic iron checks to keep ferritin in the target range. Most RLS can be managed at primary-care level; refer to a neurologist or sleep-medicine specialist for severe, refractory, complex or pregnancy cases. Indian centres with relevant expertise include AIIMS Delhi, NIMHANS Bengaluru, PGIMER Chandigarh, CMC Vellore, SCTIMST Trivandrum, KEM Mumbai and JIPMER, alongside the major private chains.

Diagnostic costs are modest. A neurology or sleep-medicine consult runs roughly Rs 800-3,000 privately, and is free or minimal at government tertiary centres. A complete blood count is around Rs 200-500, ferritin Rs 400-1,000, iron studies Rs 500-1,200, vitamin B12 Rs 500-1,200, vitamin D Rs 800-1,500, thyroid and kidney panels Rs 300-800 each. A polysomnography (sleep study), needed only if another sleep disorder is suspected, costs Rs 4,000-15,000. Many of these are covered at empanelled centres under Ayushman Bharat PMJAY.

Treatment is generally affordable. Oral iron ranges from Rs 50-500 a month and is free at PHCs under Anemia Mukt Bharat. IV iron sucrose is around Rs 800-2,500 per dose; single high-dose infusions of ferric carboxymaltose or iron isomaltoside Rs 3,000-8,000. Gabapentin is roughly Rs 200-500 a month, pregabalin Rs 600-2,000, ropinirole Rs 200-800, pramipexole Rs 300-1,000.

Several schemes ease the cost. Ayushman Bharat PMJAY covers diagnosis and treatment at empanelled hospitals for eligible families; CGHS, ECHS and ESI cover central employees; state schemes add further coverage; and Anemia Mukt Bharat supplies free iron through primary care.

Most RLS can be handled by a knowledgeable GP or physician. Refer to a specialist for severe or refractory disease, complex diagnosis, IV iron, augmentation on a dopamine agonist, difficult comorbidities, or pregnancy. The Indian Academy of Neurology (ianindia.org) and the Indian Sleep Disorders Association (sleepdisorders.org.in) maintain specialist directories, and telehealth neurology is increasingly available through platforms such as Apollo 24/7 and Practo.

See a doctor if leg sensations and an urge to move are regularly disturbing your sleep, affecting your mood or daytime functioning, or not settling with simple measures. RLS is very treatable, and persistent symptoms deserve a proper assessment rather than being written off as stress or tiredness.

Book an appointment promptly if you notice any of the following:

• American Academy of Sleep Medicine: Clinical Practice Guideline on the Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder (2024)
• International Restless Legs Syndrome Study Group (IRLSSG) diagnostic criteria
• NIH / NINDS: Restless Legs Syndrome information page
• NHS: Restless legs syndrome
• Ministry of Health and Family Welfare, India: Anemia Mukt Bharat
• National Family Health Survey (NFHS-5), India, 2019-21
• Indian Academy of Neurology